Studying the safety and moisturizing effect of Doublebase Once for ichthyosis
Part of Genetic & congenital, Skin clinical trials.
This trial tests a moisturizer called Doublebase Once in people with ichthyosis (a condition causing dry, scaly skin). For one month, you'd use this product once daily instead of your usual moisturizer to see if it works well and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ichthyosis by a doctor or other healthcare professional.
- You currently use a leave-on moisturizer (emollient) regularly to manage your condition.
- You are willing to stop using your usual moisturizer and use the study product Doublebase Once daily for one month.
- You cannot have a known allergy or sensitivity to any ingredient in Doublebase Once or similar products.
- You cannot be currently participating in another clinical trial or have done so in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This study tests whether an antibiotic called gentamicin, given as an injection, can improve symptoms of hereditary ichthyosis, a genetic skin condition that causes severe dryness and scaling. If you have moderate to severe ichthyosis due to certain gene changes, this treatment might help your skin produce the missing proteins.
This study tests whether a moisturiser called Doublebase Once is safe and works well for people with psoriasis. You would use this moisturiser instead of your usual one for about a month to see how your skin reacts and feels.
This study tests a moisturizer called Doublebase Once for people with atopic eczema. You apply it once a day for 4 weeks to see how well it improves skin moisture and eczema symptoms.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study compares two creams—one with cholesterol and one with urea—to see which better improves skin barrier and quality of life in people with ichthyosis, a condition causing dry, scaly skin. Participants will use one of the creams for a period and be monitored.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.